PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Timing of Co-occurring Chronic Conditions in Children With Neurologic Impairment. Pediatrics. 2021 Feb; 147(2). View abstract
  2. Weighing Distress and Benefit: Understanding the Research Participation Experiences of Bereaved Parents of Children With Complex Chronic Conditions. J Pain Symptom Manage. 2020 Dec 04. View abstract
  3. Toddler With New Onset Diabetes and Atypical Hemolytic-Uremic Syndrome in the Setting of COVID-19. Pediatrics. 2021 02; 147(2). View abstract
  4. Development of a Stakeholder Driven Serious Illness Communication Program for Advance Care Planning in Children, Adolescents, and Young Adults with Serious Illness. J Pediatr. 2021 Feb; 229:247-258.e8. View abstract
  5. A Breather during the Time of Breathlessness. J Palliat Med. 2021 Feb; 24(2):289. View abstract
  6. "I Could Never Prepare for Something Like the Death of My Own Child": Parental Perspectives on Preparedness at End of Life for Children With Complex Chronic Conditions. J Pain Symptom Manage. 2020 12; 60(6):1154-1162.e1. View abstract
  7. Chronic Medication Use in Children Insured by Medicaid: A Multistate Retrospective Cohort Study. Pediatrics. 2019 04; 143(4). View abstract
  8. Association of Home Respiratory Equipment and Supply Use with Health Care Resource Utilization in Children. J Pediatr. 2019 04; 207:169-175.e2. View abstract
  9. Advance Care Planning and Parent-Reported End-of-Life Outcomes in Children, Adolescents, and Young Adults With Complex Chronic Conditions. Crit Care Med. 2019 01; 47(1):101-108. View abstract
  10. Patterns of Care at the End of Life for Children and Young Adults with Life-Threatening Complex Chronic Conditions. J Pediatr. 2018 02; 193:196-203.e2. View abstract
  11. It's Very Treatable. J Palliat Med. 2018 Apr; 21(4):574-575. View abstract
  12. Saying Goodbye. JAMA Pediatr. 2017 05 01; 171(5):417. View abstract
  13. Medication Reconciliation Failures in Children and Young Adults With Chronic Disease During Intensive and Intermediate Care. Pediatr Crit Care Med. 2017 Apr; 18(4):370-377. View abstract
  14. Suspected Cerebral Edema in Diabetic Ketoacidosis: Is There Still a Role for Head CT in Treatment Decisions? Pediatr Crit Care Med. 2017 Mar; 18(3):207-212. View abstract
  15. 545: END-OF-LIFE CARE FOR CHILDREN WITH MEDICAL COMPLEXITY: DOES ADVANCE CARE PLANNING MATTER? Crit Care Med. 2016 Dec; 44(12 Suppl 1):213. View abstract
  16. 526: DO INTERMEDIATE CARE UNITS ALTER INTENSIVE CARE UTILIZATION FOR CHILDREN WITH MEDICAL COMPLEXITY? Crit Care Med. 2016 Dec; 44(12 Suppl 1):208. View abstract
  17. The authors reply. Pediatr Crit Care Med. 2014 Mar; 15(3):285-6. View abstract
  18. Increasing use of hypertonic saline over mannitol in the treatment of symptomatic cerebral edema in pediatric diabetic ketoacidosis: an 11-year retrospective analysis of mortality*. Pediatr Crit Care Med. 2013 Sep; 14(7):694-700. View abstract
  19. Caspase cascades in human immunodeficiency virus-associated neurodegeneration. J Neurosci. 2002 May 15; 22(10):4015-24. View abstract
  20. Ratio of S-nitrosohomocyst(e)ine to homocyst(e)ine or other thiols determines neurotoxicity in rat cerebrocortical cultures. Neurosci Lett. 1999 Apr 16; 265(2):103-6. View abstract
  21. Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem. 1998 Sep; 71(3):946-59. View abstract
  22. Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neurosci Lett. 1997 Nov 07; 236(3):139-42. View abstract
  23. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A. 1997 May 27; 94(11):5923-8. View abstract